Glycomimetics Inc

Glycomimetics Inc GlycoMimetics is a publicly traded, clinical-stage biotechnology company that utilizes novel and proprietary glycobiology technology to develop treatments for diseases, especially those with high unmet needs. Since the company’s inc...

Glycomimetics Inc GlycoMimetics is a publicly traded, clinical-stage biotechnology company that utilizes novel and proprietary glycobiology technology to develop treatments for diseases, especially those with high unmet needs. Since the company’s inception in 2003, GlycoMimetics has developed a robust, diversified product pipeline. The company’s mission is to continue to advance its pipeline, providing hope for patients with sickle cell, cancer, and other serious diseases.